Mode of action: NSAIDs inhibit cycloxygenase (COX), the enzyme that catalyses the
synthesis of cyclic endoperoxides, from the arachidonic acid to form PGs. The two COX
isoenzymes are COX-1 and COX-2.The function of COX-1 is to produce PGs that are involved
in normal cellular activity, (protection of gas-tric mucosa, maintenance of kidney function).
While, COX-2 is responsible for the production of PGs at the infl ammation sites. Most
NSAIDs inhibit both COX-1 and COX-2 with varying degree of selectivity.Selective COX-2
inhibitor may eliminate the side effects associated with NSAIDs due to COX-1 inhibition,such
as gastric and renal effect.
CLASSIFICATION
I. Salicylic acid derivatives: Aspirin, Diflunisal, Salsalate, Sulphasalazine.
II. p-Amino phenol derivatives: Paracetamol, Phenacetin.
III. Pyrazolidine dione derivatives: Phenyl butazone, Oxyphenbutazone, Sulphin-
pyrazone.
IV. Anthranilic acid derivatives: Mefenemic acid, Flufenemic acid, Meclofenamate.
V. Aryl alkanoic acid derivative.
a. Indole acetic acid: Indomethacin.
b. Indene acetic acid: Sulindac.
c. Pyrrole acetic acid: Tolmetin, Zormipirac.
d. P henyl acetic (propionic) acid: Ibuprofen, Diclofenac, Naproxen, Caprofen,
Fenoprofen, Keto-profen, Flurbiprofen, Ketorolac, Etodaolac.
VI. Oxicams: Piroxicam, Meloxicam, Tenoxicam.
VII. Selective COX-2 inhibitors: Celecoxib, Rofecoxib, Valdecoxib.
VIII. Gold compounds: Auronofin, Aurothioglucose, Aurothioglucamide, Aurothiomalate
sodium.
IX. Miscellaneous: Nabumetone, Nimesulide, Analgin.
X. Drug used in gout: Allopurinoll, Probenecid, sulphinpyrazone.
GENERAL STRUCTURE AND PROPERTIES OF NSAIDS
In general, NSAIDs structurally consist of an acidic moiety (carboxylic acid, enols) attached
to a planar, aromatic functionality. Some analgesics also contain a polar linking group, which
attaches the planar moiety to an additional lipophilic group. This can be represented as follows:
NSAIDs general structure
1. The NSAIDs are characterized by the following chemical/ pharmacologic properties:
2. All are relatively strong organic acids with pKa in the 3.0–5.0 range. Most, but not all,
are carboxylic acids. Thus, salt forms can be generated upon treatment with base and
all of these compounds are extensively ionized at physiologic pH. The acidic group is
essential for COX inhibitory activity.